Home › Non-Small Cell Lung Cancer › Missouri › Springfield
Non-Small Cell Lung Cancer clinical trials in Springfield, MO
10 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Springfield (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 2
- Oncology Hematology Associates, Springfield
Pan-tumor MRD Study
RecruitingObservational study
- Cox Health, Springfield
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RecruitingPhase 2
- Mercy Hospital Springfield, Springfield
- CoxHealth South Hospital, Springfield
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- Hulston Cancer Center /ID# 232226, Springfield
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
RecruitingPhase 3
- Cox Medical Center North ( Site 0133), Springfield
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- Oncology Hematology Associates, Springfield
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RecruitingPhase 3
- Mercy Hospital Springfield, Springfield
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
RecruitingObservational study
- Mercy Hospital - SPG, Springfield
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Mercy Hospital Springfield, Springfield
- Cox Health South Hospital, Springfield
GEMINI-NSCLC: NSCLC Biomarker Study
RecruitingObservational study
- Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center, Springfield
- Oncology Hematology Associates, Springfield
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN96 studies
- Boston, MA89 studies
- Los Angeles, CA87 studies
- St. Louis, MO72 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH55 studies
- Washington, DC54 studies
Other studies in Springfield
- Colorectal Cancer11 studies
- Cancer (all types)10 studies
- Breast Cancer10 studies
- Obesity7 studies
- Overweight7 studies
- Melanoma6 studies
- Lung Cancer6 studies
- Metastatic Cancer6 studies
- Ovarian Cancer5 studies
- Colon Cancer5 studies
- Endometrial Cancer4 studies
- Prostate Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.